Stage III Breast Cancer Recruiting Phase 1 / 2 Trials for Copanlisib (DB12483)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03128619Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast CancerTreatment